The Glasgow, Scotland-based firm's Panaromic Platform uses an infrared spectroscopy-based test with machine learning-developed algorithms to detect signals of cancer.

The Business Research Company's Lung Cancer Liquid Biopsy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% On All Global Market Reports With Code ONLINE30 – Stay ...

My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she needs ...

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

Global Liquid Biopsy Market Industry Overview The global liquid biopsy market was valued at $4,072.6 million in 2023 and is expected to reach $20,224.7 million by 2033, growing at a CAGR of 16.83%.

A liquid biopsy is a blood test that more and more oncologists are using to help detect and treat lung cancer. Learn about ...

Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” first quarter 2025 ...

GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, ...

This application note outlines a comprehensive workflow for MRD detection, using a next-generation sequencing (NGS) approach ...

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

Liquid biopsy testing can reveal more about cancers because it picks up DNA from cells all across tumors. “As you can imagine, if you biopsy one tiny piece of tumor, you might miss the mutation that’s ...